Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Effect of tolvaptan on serum sodium in those patients presenting with initial sodium under 135 mEq/ in the Acute and Chronic Therapeutic Impact of a Vasopressin (ACTIV) trial. Adapted from reference 55. White bars = placebo; black bars = 30 mg; dotted bars = 60 mg; grey bars = 90 mg.
|
